Cover image of the article: Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study

Image Credit:J Inflamm Dis

Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study

Authors

Majid Vafaie1, Hamid Sadeghi1, Hamid Sadeghi2, Saeideh Gholamzadeh KhoeiSaeideh Gholamzadeh Khoei ORCID3,*
1Clinical Research Development Unit, Qods Hospital, Qazvin University of Medical Sciences, Qazvin, Iran.
2Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
3Clinical Research Development Unit, Kowsar Hospital, Qazvin University of Medical Sciences, Qazvin, Iran.
*Corresponding Author: Clinical Research Development Unit, Kowsar Hospital, Qazvin University of Medical Sciences, Qazvin, Iran. Email: s.gholamzade@yahoo.com

Journal of Inflammatory Diseases:Vol. 26, issue 4; 209-216
Published online:Mar 31, 2023
Article type:Research Article
How to Cite:Vafaie M, Sadeghi H, Sadeghi H, Gholamzadeh Khoei S. Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study. J Inflamm Dis. 2024;26(4):e156328. doi:

Abstract

Background: Acute lymphoblastic leukemia (ALL) is the most prevalent childhood cancer. ALL is a heterogeneous type of malignancy and treatment protocols vary based on the immunological classification of ALL. The critical step for treating ALL is to identify immunological subgroups by flow cytometry findings.  Objective: In this study, immunophenotypic information was evaluated for the first time in children with ALL in Qazvin City, Iran. Methods: This cross-sectional study reviewed the clinical and laboratory data of children with ALL during 2019-2020. Next, children with ALL were immunophenotyped by flow cytometry applying a panel of the specific monoclonal antibodies for some clusters of differentiation (CD) molecules, including CD20, CD21, CD10, CD34, CD38, and terminal deoxynucleotidyl transferase (TdT). The data were separately analyzed using SPSS software, version 24. Findings: Of 52 children with ALL in the age range of 6 months to 15 years, 23 children (44.23%) had B-ALL-ProB (pro-B) cell immunotyping features, 26 (50%) had B-ALL-PreB (pre-B) cell immunotyping features, and 3 (5.7%) had T-cell immunotyping features. The ages of T-cell group children were higher than those of B-cell group children. The most common clinical and laboratory findings were fever (26 cases, 55.31%). In 55% of children, periodic acid-schiff (PAS) staining was positive. The presence of the terminal deoxynucleotidyl transferase (TdT) enzyme was higher in B-cell patients than in T-cell cases. Children with CD34+ were higher in the pro-B group than in the pre-B group.  Conclusion: our study shows that the immunophenotypic characteristics of children with ALL are more similar to previous reports and can be used for monitoring and prognosis of children with ALL in Qazvin City.

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

6
Oct
2024
Comparative Evaluation of the Immunophenotypic Profile of Acute Lymphoblastic Leukaemia in Adult and Paediatric Age Groups in Iraq

Comparative Evaluation of the Immunophenotypic Profile of Acute Lymphoblastic Leukaemia in Adult and Paediatric Age Groups in Iraq

Enass Abdul Kareem Al-Saadi,
Marwa Ali Abdulnabi,
Israa M Al-Bayaa

Al-Saadi EAK, Abdulnabi MA, Al-Bayaa IM. Comparative Evaluation of the Immunophenotypic Profile of Acute Lymphoblastic Leukaemia in Adult and Paediatric Age Groups in Iraq. Shiraz E-Med J. 2024;25(11):e143003. doi: https://doi.org/10.5812/semj-143003

21
May
2014
The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia

The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia

Fatemeh M. Kamazani,
Gholamreza Bahoush-Mehdiabadi,
Mahnaz Aghaeipour,
Shahram Vaeli,
Zahra Amirghofran

M. Kamazani F, Bahoush-Mehdiabadi G, Aghaeipour M, Vaeli S, Amirghofran Z. The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia. Inn J Pediatr. 2014;24(4):. doi:

30
Sep
2012
Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan)

Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan)

Mohammad Ali Mashhadi,
Mohhamad Mahdi Koushyar,
Mehdi Mohammadi

Mashhadi MA, Koushyar MM, Mohammadi M. Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan). Int J Cancer Manag. 2012;5(3):e80814. doi:

30
Sep
2012
Demographic and Prognostic Factors of 455 Patients with Acute Leukemia Admitted to Two Referral Hospitals in Tehran-Iran During Ten Years (2001-2011)

Demographic and Prognostic Factors of 455 Patients with Acute Leukemia Admitted to Two Referral Hospitals in Tehran-Iran During Ten Years (2001-2011)

Parvin Ayremlou,
Seyed Mohsen Razavi,
Masoud Solaymani-Dodaran,
Masoud Vakili,
Mohsen Asadi-Lari

Ayremlou P, Razavi SM, Solaymani-Dodaran M, Vakili M, Asadi-Lari M. Demographic and Prognostic Factors of 455 Patients with Acute Leukemia Admitted to Two Referral Hospitals in Tehran-Iran During Ten Years (2001-2011). Int J Cancer Manag. 2012;5(3):e80921. doi:

10
Aug
2016
The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia

The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia

Abolghasem Allahyari,
Seyed-Mehdi Hashemi,
Fahimeh Nazemian,
Mohammad Karimi,
Mohammad-Reza Kazemi,
Masoud Sadeghi

Allahyari A, Hashemi S, Nazemian F, Karimi M, Kazemi M, et al. The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia. Int J Cancer Manag. 2016;9(4):e5045. doi: https://doi.org/10.17795/ijcp-5045

More by these authors

Majid VafaiePubMedScholar
Hamid SadeghiPubMedScholar
Hamid SadeghiPubMedScholar
Saeideh Gholamzadeh KhoeiPubMedScholar
Share
Cited by
Metrics
Indexed in